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Treatment by place of residence
Table 1 Benzodiazepine cases entering treatment, by HSE region of residence (NDTRS 2003–2008)
2003 2004 2005 2006 2007 2008
n (%) n (%) n (%) n (%) n (%) n (%)
All cases 1054 1026 1115 1222 1225 1719
Dublin North East 384 (36.4) 314 (30.6) 374 (33.5) 402 (32.9) 371 (30.3) 487 (28.3)
Dublin Mid-Leinster 527 (50.0) 517 (50.4) 491 (44.0) 553 (45.3) 505 (41.2) 742 (43.2)
South 108 (10.2) 145 (14.1) 195 (17.5) 183 (15.0) 207 (16.9) 310 (18.0)
West 35 (3.3) 50 (4.9) 55 (4.9) 84 (6.9) 142 (11.6) 180 (10.5)
Table 2 Cases entering treatment who reported a benzodiazepine as their main problem 
substance, by HSE region of residence and by treatment status (NDTRS 2003–2008)
2003 2004 2005 2006 2007 2008
n (%) n (%) n (%) n (%) n (%) n (%)
All cases 76 103 75 96 163 167
Dublin North East 13 (17.1) 23 (22.3) 15 (20.0) 23 (24.0) 49 (30.1) 48 (28.7)
Dublin Mid-Leinster 20 (26.3) 25 (24.3) 13 (17.3) 20 (20.8) 42 (25.8) 27 (16.2)
South 36 (47.4) 43 (41.7) 37 (49.3) 44 (45.8) 46 (28.2) 46 (27.5)
West 7 (9.2) 12 (11.7) 10 (13.3) 9 (9.4) 26 (16.0) 46 (27.5)
Previously treated cases 49 50 30 40 72 87
Dublin North East 9 (18.4) 14 (28.0) 6 (20.0) 11 (27.5) 22 (30.6) 26 (29.9)
Dublin Mid-Leinster 17 (34.7) 15 (30.0) 8 (26.7) 6 (15.0) 26 (36.1) 17 (19.5)
South 19 (38.8) 16 (32.0) 13 (43.3) 19 (47.5) 18 (25.0) 23 (26.4)
West ~ 5 (10.0) ~ ~ 6 (8.3) 21 (24.1)
New cases 27 47 42 50 85 74
Dublin North East ~ 9 (19.1) 8 (19.0) 12 (24.0) 26 (30.6) 19 (25.7)
Dublin Mid-Leinster ~ 8 (17.0) ~ 11 (22.0) 16 (18.8) 10 (13.5)
South 17 (63.0) 25 (53.2) 23 (54.8) 22 (44.0) 24 (28.2) 23 (31.1)
West ~ 5 (10.6) 7 (16.7) 5 (10.0) 19 (22.4) 22 (29.7)
Treatment status not known 0 6 ~ 6 6 6
~ Less than five cases
Table 3 Cases entering treatment who reported a benzodiazepine as an additional problem 
substance, by HSE region of residence and by treatment status (NDTRS 2003–2008)
2003 2004 2005 2006 2007 2008
n (%) n (%) n (%) n (%) n (%) n (%)
All cases 982 928 1044 1129 1064 1562
Dublin North East 371 (37.8) 291 (31.4) 359 (34.4) 381 (33.7) 322 (30.3) 441 (28.2)
Dublin Mid-Leinster 507 (51.6) 493 (53.1) 478 (45.8) 533 (47.2) 464 (43.6) 715 (45.8)
South 75 (7.6) 106 (11.4) 160 (15.3) 140 (12.4) 162 (15.2) 269 (17.2)
West 29 (3.0) 38 (4.1) 47 (4.5) 75 (6.6) 116 (10.9) 137 (8.8)
Previously treated cases 770 711 782 802 715 1032
Dublin North East 300 (39.0) 230 (32.3) 263 (33.6) 244 (30.4) 202 (28.3) 248 (24.0)
Dublin Mid-Leinster 405 (52.6) 390 (54.9) 395 (50.5) 451 (56.2) 378 (52.9) 573 (55.5)
South 50 (6.5) 67 (9.4) 93 (11.9) 73 (9.1) 74 (10.3) 141 (13.7)
West 15 (1.9) 24 (3.4) 31 (4.0) 34 (4.2) 61 (8.5) 70 (6.8)
New cases 188 186 235 302 332 505
Dublin North East 61 (32.4) 45 (24.2) 86 (36.6) 126 (41.7) 115 (34.6) 181 (35.8)
Dublin Mid-Leinster 89 (47.3) 94 (50.5) 68 (28.9) 71 (23.5) 78 (23.5) 134 (26.5)
South 25 (13.3) 37 (19.9) 66 (28.1) 64 (21.2) 86 (25.9) 124 (24.6)
West 13 (6.9) 10 (5.4) 15 (6.4) 41 (13.6) 53 (16.0) 66 (13.1)
Treatment status not known 24 31 27 25 17 25
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Table 4 Benzodiazepine cases entering treatment, by place of residence (Dublin or outside Dublin) 
(NDTRS 2003–2008)
2003 2004 2005 2006 2007 2008
n (%) n (%) n (%) n (%) n (%) n (%)
All cases 1054 1026 1115 1222 1225 1719
Dublin 822 (78.0) 741 (72.2) 791 (70.9) 827 (67.7) 726 (59.3) 1077 (62.7)
Outside Dublin 232 (22.0) 285 (27.8) 324 (29.1) 395 (32.3) 499 (40.7) 642 (37.3)
Previously treated cases 816 758 810 839 787 1113
Dublin 666 (81.6) 589 (77.7) 625 (77.2) 641 (76.4) 549 (69.8) 779 (70.0)
Outside Dublin 150 (18.4) 169 (22.3) 185 (22.8) 198 (23.6) 238 (30.2) 334 (30.0)
New cases 214 231 275 352 415 576
Dublin 134 (62.6) 127 (55.0) 142 (51.6) 166 (47.2) 167 (40.2) 278 (48.3)
Outside Dublin 80 (37.4) 104 (45.0) 133 (48.4) 186 (52.8) 248 (59.8) 298 (51.7)
Treatment status not known 24 37 30 31 23 30
Table 5 Cases entering treatment who reported a benzodiazepine as their main problem 
substance, by place of residence (Dublin or outside Dublin) (NDTRS 2003–2008)
2003 2004 2005 2006 2007 2008
n (%) n (%) n (%) n (%) n (%) n (%)
All cases 76 103 75 96 163 167
Dublin 23 (30.3) 39 (37.9) 17 (22.7) 27 (28.1) 64 (39.3) 64 (38.3)
Outside Dublin 53 (69.7) 64 (62.1) 58 (77.3) 69 (71.9) 99 (60.7) 103 (61.7)
Previously treated cases 49 50 30 40 72 87
Dublin 18 (36.7) 25 (50.0) 9 (30.0) 14 (35.0) 41 (56.9) 38 (43.7)
Outside Dublin 31 (63.3) 25 (50.0) 21 (70.0) 26 (65.0) 31 (43.1) 49 (56.3)
New cases 27 47 42 50 85 74
Dublin 5 (18.5) 13 (27.7) 7 (16.7) 10 (20.0) 22 (25.9) 23 (31.1)
Outside Dublin 22 (81.5) 34 (72.3) 35 (83.3) 40 (80.0) 63 (74.1) 51 (68.9)
Treatment status not known 0 6 ~ 6 6 6
~ Less than five cases
Table 6 Cases entering treatment who reported a benzodiazepine as an additional problem 
substance, by place of residence (Dublin or outside Dublin) (NDTRS 2003–2008)
2003 2004 2005 2006 2007 2008
n (%) n (%) n (%) n (%) n (%) n (%)
All cases 982 928 1044 1129 1064 1562
Dublin 799 (81.4) 702 (75.6) 774 (74.1) 802 (71.0) 663 (62.3) 1015 (65.0)
Outside Dublin 183 (18.6) 226 (24.4) 270 (25.9) 327 (29.0) 401 (37.7) 547 (35.0)
Previously treated cases 770 711 782 802 715 1032
Dublin 648 (84.2) 564 (79.3) 616 (78.8) 629 (78.4) 508 (71.0) 742 (71.9)
Outside Dublin 122 (15.8) 147 (20.7) 166 (21.2) 173 (21.6) 207 (29.0) 290 (28.1)
New cases 188 186 235 302 332 505
Dublin 129 (68.6) 114 (61.3) 135 (57.4) 156 (51.7) 146 (44.0) 255 (50.5)
Outside Dublin 59 (31.4) 72 (38.7) 100 (42.6) 146 (48.3) 186 (56.0) 250 (49.5)
Treatment status not known 24 31 27 25 17 25
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Table 7 New benzodiazepine cases entering treatment, by county of residence (NDTRS 2003–
2008)
Number %




























~ Less than five cases
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Figure 1 Average annual incidence of cases treated for a benzodiazepine as their main problem 
substance per 100,000 of the 15–64-year-old population, by county of residence (NDTRS 





















































0 to 0.9 cases per 100,000
1 to 1.9 cases per 100,000
2 to 2.9 cases per 100,000
3 or more cases per 100,000
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Table 8 New benzodiazepine cases entering treatment, by local health office (LHO) area of 
residence (NDTRS 2003–2008)
Number %
All cases 2063 100
Cork 361 17.5
Dublin North Central 256 12.4
Dublin North West 215 10.4
Dublin West 134 6.5
Dublin South West 133 6.4
Dublin North 129 6.3
Dublin South City 98 4.8
Limerick (excluding East Limerick) 87 4.2
Wexford 68 3.3
Longford and Westmeath 53 2.6
Carlow and Kilkenny 46 2.2
Louth 45 2.2
Kildare and South West Wicklow 43 2.1
Galway 41 2.0
Dublin South 33 1.6
Donegal 31 1.5
Wicklow East Coast 31 1.5
Laois and Offaly 30 1.5
Meath 30 1.5
Kerry 26 1.3
Tipperary NR and East Limerick 26 1.3
Waterford 26 1.3
Sligo and Leitrim 23 1.1
Clare 17 0.8
Cavan and Monaghan 17 0.8
Dublin South East 16 0.8
Mayo 16 0.8
Roscommon 15 0.7
Tipperary SR 15 0.7
LHO area unknown 2 0.1
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Figure 2 Average annual incidence of cases treated for a benzodiazepine as their main problem 
substance per 100,000 of the 15–64-year-old population, by local health office area of 




















































1. Dublin South (0.2)
2. Dublin South East (0.0)
3. Dublin South City (0.6)
4. Dublin South West (1.5)
5. Dublin West (0.8)
6. Dublin North West (2.0)
7. Dublin North Central (5.4)
8. Dublin North (1.0)
0 to 0.9 cases per 100,000
1 to 1.9 cases per 100,000
2 to 2.9 cases per 100,000
3 or more cases per 100,000
Cork
3.7
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Table 9 New benzodiazepine cases entering treatment, by local drugs task force (LDTF) area of 
residence (NDTRS 2003–2008)
Number %
All new cases 2063 100
North Inner City 190 9.2
Finglas–Cabra 105 5.1
Dublin North East 105 5.1
Ballymun 89 4.3
Tallaght 87 4.2
South Inner City 77 3.7
Clondalkin 71 3.4
Ballyfermot 45 2.2
Dun Laoghaire–Rathdown 45 2.2
Blanchardstown 44 2.1
Dublin 12 44 2.1
Canal Communities 19 0.9
Bray 10 0.5
Rest of Dublin 157 7.6
Outside Dublin 973 47.2
LDTF area unknown 2 0.1
Additional problem substances
Table 10 Number of additional problem substances used by cases entering treatment who reported 
a benzodiazepine as their main problem substance, by treatment status (NDTRS 2003–
2008)
2003 2004 2005 2006 2007 2008
n (%) n (%) n (%) n (%) n (%) n (%)
All cases 76 103 75 96 163 167
One drug 19 (25.0) 30 (29.1) 16 (21.3) 21 (21.9) 28 (17.2) 38 (22.8)
Two drugs 32 (42.1) 25 (24.3) 24 (32.0) 34 (35.4) 56 (34.4) 48 (28.7)
Three drugs 15 (19.7) 26 (25.2) 15 (20.0) 20 (20.8) 33 (20.2) 41 (24.6)
Four drugs 10 (13.2) 22 (21.4) 20 (26.7) 21 (21.9) 46 (28.2) 40 (24.0)
Previously treated cases 49 50 30 40 72 87
One drug 16 (32.7) 5 (10.0) 7 (23.3) 7 (17.5) 8 (11.1) 12 (13.8)
Two drugs 18 (36.7) 14 (28.0) 8 (26.7) 18 (45.0) 30 (41.7) 25 (28.7)
Three drugs 10 (20.4) 18 (36.0) 6 (20.0) 8 (20.0) 13 (18.1) 29 (33.3)
Four drugs 5 (10.2) 13 (26.0) 9 (30.0) 7 (17.5) 21 (29.2) 21 (24.1)
New cases 27 47 42 50 85 74
One drug 3 (11.1) 23 (48.9) 8 (19.0) 11 (22.0) 19 (22.4) 22 (29.7)
Two drugs 14 (51.9) 8 (17.0) 14 (33.3) 16 (32.0) 26 (30.6) 22 (29.7)
Three drugs 5 (18.5) 7 (14.9) 9 (21.4) 10 (20.0) 18 (21.2) 12 (16.2)
Four drugs 5 (18.5) 9 (19.1) 11 (26.2) 13 (26.0) 22 (25.9) 18 (24.3)
Treatment status unknown 0 6 3 6 6 6
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Patterns of benzodiazepine use
Table 11 Route of administration for cases entering treatment who reported a benzodiazepine as 
their main problem substance, by treatment status (NDTRS 2003–2008)
2003 2004 2005 2006 2007 2008
n (%) n (%) n (%) n (%) n (%) n (%)
All cases 76 103 75 96 163 167
Inject ~ ~ 0 (0.0) 0 (0.0) 0 (0.0) ~
Smoke 0 (0.0) 0 (0.0) 0 (0.0) ~ ~ 0 (0.0)
Eat or drink 74 (97.4) 101 (98.1) 74 (98.7) 94 (97.9) 159 (97.5) 165 (98.8)
Not known 0 (0.0) ~ ~ ~ ~ ~
Previously treated cases 49 50 30 40 72 87
Inject ~ ~ 0 (0.0) 0 (0.0) 0 (0.0) ~
Smoke 0 (0.0) 0 (0.0) 0 (0.0) ~ 0 (0.0) 0 (0.0)
Eat or drink 47 (95.9) 49 (98.0) 30 (100.0) 39 (97.5) 71 (98.6) 85 (97.7)
Not known 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) ~ ~
New cases 27 47 42 50 85 74
Eat or drink 27 (100.0) 46 (97.9) 41 (97.6) 50 (100.0) 83 (97.6) 74 (100.0)
Not known 0 (0.0) ~ ~ 0 (0.0) ~ 0 (0.0)
Treatment status unknown 0 6 3 6 6 6
~ Less than five cases
Table 12 Frequency of benzodiazepine use in the month prior to entering treatment by cases who 
reported a benzodiazepine as their main problem substance, by treatment status (NDTRS 
2003–2008)
2003 2004 2005 2006 2007 2008
n (%) n (%) n (%) n (%) n (%) n (%)
All cases 76 103 75 96 163 167
No use in the last month 11 (14.5) 22 (21.4) 8 (10.7) 10 (10.4) 19 (11.7) 26 (15.6)
Once a week or less ~ ~ ~ ~ 9 (5.5) 9 (5.4)
2–6 times per week 10 (13.2) 8 (7.8) 10 (13.3) 14 (14.6) 19 (11.7) 25 (15.0)
Daily 49 (64.5) 64 (62.1) 52 (69.3) 61 (63.5) 106 (65.0) 101 (60.5)
Not known ~ 6 (5.8) ~ 7 (7.3) 10 (6.1) 6 (3.6)
Previously treated cases 49 50 30 40 72 87
No use in the last month 8 (16.3) 9 (18.0) ~ 5 (12.5) 10 (13.9) 16 (18.4)
Once a week or less ~ ~ 0 (0.0) ~ ~ 6 (6.9)
2–6 times per week 7 (14.3) ~ ~ 7 (17.5) 9 (12.5) 14 (16.1)
Daily 29 (59.2) 34 (68.0) 24 (80.0) 23 (57.5) 48 (66.7) 48 (55.2)
Not known ~ ~ ~ ~ ~ ~
New cases 27 47 42 50 85 74
No use in the last month ~ 12 (25.5) 6 (14.3) ~ 9 (10.6) 10 (13.5)
Once a week or less 0 (0.0) ~ ~ ~ ~ ~
2–6 times per week ~ ~ 6 (14.3) 7 (14.0) 10 (11.8) 11 (14.9)
Daily 20 (74.1) 26 (55.3) 27 (64.3) 35 (70.0) 56 (65.9) 48 (64.9)
Not known ~ ~ ~ ~ 6 (7.1) ~
Treatment status unknown 0 6 ~ 6 6 6
~ Less than five cases
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Table 13 Cases entering treatment who reported a benzodiazepine as their main problem 
substance, by age group and by gender (NDTRS 2003–2008)
Male Female Gender not recorded
Age group n (%) n (%) n (%)
All cases 406 270 4
17 years or under 52 (12.8) 13 (4.8) ~
18–19 43 (10.6) 12 (4.4) 0 (0.0)
20–24 86 (21.2) 42 (15.6) ~
25–29 81 (20.0) 36 (13.3) ~
30–34 50 (12.3) 39 (14.4) 0 (0.0)
35–39 39 (9.6) 31 (11.5) ~
40–44 21 (5.2) 33 (12.2) 0 (0.0)
45–49 17 (4.2) 28 (10.4) 0 (0.0)
50 years or over 16 (3.9) 34 (12.6) 0 (0.0)
Age not recorded ~ ~ 0 (0.0)
~ Less than five cases
Table 14 Cases entering treatment who reported a benzodiazepine as their main problem 
substance, by age first used benzodiazepines and by gender (NDTRS 2003–2008)
Male Female Gender not recorded
Age first used n (%) n (%) n (%)
All cases 406 270 4
14 years or under 68 (16.7) 29 (10.7) ~
15–19 148 (36.5) 67 (24.8) ~
20–24 63 (15.5) 33 (12.2) ~
25–29 34 (8.4) 33 (12.2) 0 (0.0)
30–34 15 (3.7) 25 (9.3) 0 (0.0)
35–39 5 (1.2) 18 (6.7) 0 (0.0)
40–44 6 (1.5) 8 (3.0) 0 (0.0)
45–49 ~ 6 (2.2) 0 (0.0)
50 years or over 6 (1.5) 8 (3.0) 0 (0.0)
Age first used not recorded 59 (14.5) 43 (15.9) 0 (0.0)
~ Less than five cases
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Treatment provision
Figure 3 Percentage of cases entering treatment who reported a benzodiazepine as their main 
problem substance, by type of initial treatment intervention availed of (NDTRS 2008)
Figure 4 Percentage of cases entering treatment who reported a benzodiazepine as their main 
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